The cIAP2-MALT1 chimeric protein lacks E3 activity, and it leads to a decrease in ubiquitinylation and cleavage of cIAP2 and MALT1 target Bcl10 in MALT lymphomas. The gene discussed is MALT1; the disease is MALT lymphoma.